Absorption of antisense oligonucleotides in rat intestine: Effect of chemistry and length

Antisense and Nucleic Acid Drug Development

Volumn 10, Issue 1, 2000, Pages 35-44

  Khatsenko, Oleg ^a   Morgan, Ryan ^a   Truong, Loanne ^a   York Defalco, Cathie ^a   Sasmor, Henri ^a   Conklin, Boyd ^a   Geary, Richard S ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYTOSINE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; OLIGORIBONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DNA METHYLATION; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0034060189     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.2000.10.35     Document Type: Article

References (35)

1. AGRAWAL, S., and IYER, R.P. (1997). Perspectives in antisense therapeutics. Pharmacol. Ther. 76, 151-160.
2. AGRAWAL, S., and ZHANG, R. (1998). Pharmacokinetics and bioavailability of antisense oligonucleotides following oral and colorectal administrations in experimental animals. In: Handbook of Experimental Pharmacology, "Antisense Research and Application." S.T. Crooke, ed. (Springer-Verlag, Berlin, Heidelberg), vol. 131, 525-543.
3. AGRAWAL, S., ZHANG, X., LU, Z., ZHAO, H., TAMBURIN, J.M., YAN, J., CAI, H., DIASIO, R.G., HABUS, I., JLANG, Z., IYER, R.P., YU, D., and ZHANG, R. (1995). Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration. Biochem. Pharmacol. 50, 571-576.
4. ANDRADE, M., SCOZZARI, A., COLE, D.L., and RAVIJUMAR, V.T. (1994). Efficient synthesis of antisense oligodeoxyribonucleotide phosphorothioates. Bioorg. Med. Chem. Lett. 4, 2017-2022.
5. BRAND, R.M., WAHL, A., and IVERSEN, P.L. (1997). Effects of size and sequence on the iontophoretic delivery of oligonucleotides. J. Pharm. Sci. 87, 49-52.
6. CROOKE, S.T., GRAHAM, M.J, ZUCKERMAN, J.E., BROOKS, D., CONKLIN, B.S., CUMMINS, L.L., GREIG, M.J., GUINOSSO, C.J., KORNBRUST, D., MANOHARAN, M., SASMOR, H.M., SCHLEICH, T., TIVEL, K.L., and GRIFFEY, R.H. (1996). Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J. Pharm. Exp. Ther. 277, 923-937.
7. CUMMINS, L.L., OWENS, S.R., RISEN, L.M., LESNIK, E.A., FREIER, S.M., McGEE, D., GUINOSSO, C.J., and COOK, P.D. (1995). Characterization of fully 2′-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity. Nucleic Acids Res. 23, 2019-2024.
8. DEAN, N.M., and GRIFFEY, R.H. (1997). Identification and characterization of second-generation antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 7, 229-233.
9. DOLUISIO, J.T., BILLUPS, N.F., DITTERT, L.W., SUGITA, E.T., and SWINTOSKY, J.V. (1969). Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates. J. Pharm. Sci. 58, 1196-1200.
10. FLANAGAN, W.M. (1998). Antisense comes of age. Cancer Metastasis Rev. 17, 169-176.
11. GEARY, R.S. LEEDS, J.M., FITCHETT, J., BURCKIN, T., TROUNG, L., SPAINHOUR, C., CREEK, M., and LEVIN, A.A. (1997a). Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression. Drug Metab. Dispos. 25, 1272-1281.
12. GEARY, R.S., LEEDS, J.M., HENRY, S.P., MONTEITH, D.M., and LEVIN, A.A. (1997b). Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides. Anti-Cancer Drug Design 12, 383-394.
13. GLOVER, J.M., LEEDS, J.M., MANT, T.G.K., KISNER, D.L., ZUCKERMAN, J., LEVIN, A.A., and SHANAHAN, W.R. (1997). Phase I safety and pharmacokinetic profile of an ICAM-1 antisense oligodeoxynucleotide (ISIS 2302). J. Pharm. Exp. Ther. 282, 1173-1180.
14. HANSS, B., LEAL-PINTO, E., BRUGGEMAN, L.A., COPELAND, T.D., and KLOTMAN, P.E. (1998). Identification and characterization of a cell membrane nucleic acid channel. Proc. Natl. Acad. Sci. USA 95, 1921-1926.
15. HENRY, S.P., MONTEITH, D., BENNETT, C.F., and LEVIN, A.A. (1997). Toxicological and pharmacokinetic properties of chemically modified antisense oligonucleotide inhibitors of PKC-alpha and C-raf kinase. Anti-Cancer Drug Design 12, 409-420.
16. MIRAI, T., MATSUMOTO, S., and KISHI, I. (1997). Simultaneous analysis of several non-steroidal anti-inflammatory drugs in human urine by high-performance liquid chromatography with normal solid-phase extraction. J. Chromatogr. Biomed. Sci. Appl. 692, 375-388.
17. HUGHES, J., AVROUTSKAYA, A., SASMOR, H.M., GUINOSSO, C.J., DAN COOK, P., and JULIANO, R.L. (1995). Oligonucleotide transport across membranes and into cells: Effects of chemical modifications. In: Delivery Strategies Antisense Oligonucleotide Therapy. S. Akhtar, ed. (CRC Press, Boca Raton, FL), pp. 191-198.
18. IVERSEN, P.L., CROUSE, D., ZON, G., and PERRY, G. (1992). Binding of antisense phosphorothioate oligonucleotides to murine lymphocytes is lineage specific and inducible. Antisense Res. Dev. 2, 223-233.
19. KOMIYA, J., PARK, A., KAMANI, A., HO, N.F.H., and HIGUCHI, W.J. (1980). Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int. J. Pharm. 4, 249-262.
20. LANE, M.E., O'DRISCOLL, C.M., and CORRIGAN, O.I. (1996). The relationship between rat intestinal permeability and hydrophilic probe size. Pharm. Res. 13, 1554-1558.
21. LEEDS, J.M., GRAHAM, M.J., TROUNG, L., and CUMMINS, L.L. (1996). Quantitation of phosphorothioate oligonucleotides in human plasma. Anal. Biochem. 235, 36-43.
22. LEEDS, J.M., HENRY, S.P., TRUONG, L., ZUTSI, A., LEVIN, A.A., and KORNBRUST, D.J. (1997). Pharmacokinetics of a potential human cytomegalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injections in the rabbit. Drug Metab. Dispos. 25, 921-926.
23. LORE, S.L., STEIN, C.A., ZHANG, X.H., MORI, K., NAKANISHI, M., SUBASINGHE, C., COHEN, J.S., and NECKERS, L.M. (1989). Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA 86, 3474-3478.
24. MANOHARAN, M., JOHNSON, L.K., McGEE, D.P.C., GUINOSSO, C.J., RAMASAMY, K., SPRINGER, R.H., BENNETT, C.F., ECKER, D.J., VICKERS, T., COWSERT, L., and COOK, P.D. (1992). Chemical modifications to improve uptake and bioavailability of antisense. Ann. NY Acad. Sci. 660, 306-309.
25. METELEV, V., LISZIEWWICZ, J., and AGRAWAL, S. (1994). Study of antisense oligonucleotide phosphorothioates containing segments of oligodeoxynucleotides and 2′-O-methyloligoribonucleotides. Bioorg. Med. Chem. 4, 2929-2934.
26. MONIA, B.P., LESNIK, E.A., GONZALEZ, C., LIMA, W.F., McGEE, D., GUINOSSO, C.J., KAWASAKI, A.M., COOK, P.D., and FREIER, S.M. (1993). Evaluation of 2′-modified oligonucleotides containing deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268, 14514-14522.
27. NICKLIN, P.L., BAYLEY, D., GIDDINGS, J., CRAIG, S.J., CUMMINS, L.L., HASTEWELL, J.G., and PHILLIPS, J.A. (1998). Pulmonary bioavailability of a phosphorothioate oligonucleotide (CGP 64128A): Comparison with other delivery routes. Pharm. Res. 15, 583-591.
28. OLDENBURG, K.R., VO, K.T., SMITH, G.A., and SELICK, H.E. (1995). Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin. J. Pharm. Sci. 84, 915-921.
29. PREECE, A. (1972). A Manual for Histologic Technicians, 3rd ed. (Little Brown, Boston).
30. SNEDECOR, G.W., and COCHRAN, W.G. (1980). Statistical Methods, 7th ed. (Iowa State University Press, Ames, IA).
31. STEIN, C.A., TONKINSON, J.L., ZHANG, L.-M., YAKUBOV, L., GERVASONI, J., TAUB, R., and ROTENBERG, S.A. (1993). Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry 32, 4855-4861.
32. STIX, G. (1998). Shutting down a gene. Antisense drug wins approval. Sci. Am. 279, 46-50.
33. VONDERSCHER, J., BURI, P., DESHUSSES, J., and SUCKER, H. (1990). Absorption rate of drugs in rats. Application of the improved modified Doluisio method to various classes of drugs. Acta Pharm. Technol. 36, 133-138.
34. YAKUBOV, L.A., DEEVA, E.A., ZARYTOVA, V.F., IVANOVA, E.M., RYTE, A.S., YURCHENKO, L.V., and VLASSOV, V.V. (1980). Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors? Proc. Natl. Acad. Sci. USA 86, 6454-6458.
35. ZHANG, R., LU, Z., ZHANG, X., ZHAO, H., DIASIO, R.B., LIU, T., JIANG, Z., and AGRAWAL, S. (1995). In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in rats. Clin. Chem. 41, 836-843.